Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Aliquoting Liquid Handler Enhances Laboratory Efficiency

By LabMedica International staff writers
Posted on 26 Sep 2011
A newly developed automated aliquoting liquid handler accurately dispenses liquid volumes from 100 µL to 875 µL and process up to 1,000 samples per hour. More...
The second-generation platform enhances laboratory efficiency through workflow automation.

Introduced by Thermo Fisher Scientific (Waltham, MA, USA), the CV2000 provides convenience and safety with active opening and closing systems and locking guards that meet the US Department of Labor's Occupational Safety and Health Administration regulations.

The CV2000 system is fully compatible with multiple rack formats and permits users to change the loading and dispensing routine to suit their needs. A unique tip preservation system allows the instrument to discharge used tips only, reducing waste while eliminating contamination. Capable of holding up to 300 samples and accommodating both 45 mL and 90 mL urine containers, the system can automate the process of aliquoting urine from primary samples to analyzer racks. In addition, the CV2000 system creates a batch report that is compatible with downstream analysis instrumentation, which is used to process the urine samples.

With its robotic arm and rotary height sensors, the CV2000 fits easily into automated workflows to boost sample throughput. The system is compatible with a wide variety of sample management software, but can also be used as a stand-alone instrument. It effectively manages samples to boost efficiency and productivity with zero cross-contamination.

Related Links:

Thermo Fisher Scientific



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
Urine Chemistry Control
Dropper Urine Chemistry Control
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LungCanSeek demonstrated an overall sensitivity of 83.5% and specificity of 90.3% in detecting lung cancer (Photo courtesy of AdobeStock)

New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

Lung cancer remains the leading cause of cancer-related deaths worldwide, largely because most cases are diagnosed at advanced stages when treatment options are limited. Early detection significantly improves... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.